Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineDaniel E. Neafsey, Carsten Russ, Dyann F. Wirth et al.|New England Journal of Medicine|2015Cited by 451
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgePhilip Bejon, Lorenz von Seidlein|New England Journal of Medicine|2008Cited by 414
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in KenyaPhilip Bejon, Kevin Marsh|PLoS Medicine|2010Cited by 300
A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspotsPhilip Bejon, Steffen Borrmann, Thomas N. Williams et al.|eLife|2014Cited by 149